Clinical Evaluation of the Application of the FilmArray GI Panel in Post-HSCT Diarrhea Patients
NCT ID: NCT03894488
Last Updated: 2019-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2019-06-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma
NCT06228963
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
NCT06943768
Analysis of the Clinical and Histological Correlation of Oral Graft-Versus-Host-Disease (GVHD)
NCT00898885
MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding
NCT06698874
Impact of the Introduction of a Gastro-intestinal Panel by Polymerase Chain Reaction (PCR).
NCT03551340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FilmArray Gastrointestinal (GI) Panel
The FilmArray GI Panel tests for 22 of the most commonly associated pathogens related to gastroenteritis-all from one patient sample, one easy to use reagent, and results are available in about one hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving HSCT;
* Legal guardians fully understand and sign informed consent.
Exclusion Criteria
* Cannot give informed consent or not willing to enroll the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioMérieux
INDUSTRY
Shanghai Children's Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cao Qing
Director of Infectious Diseases
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GI-GVHD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.